More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro™ to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression.
Just like the OCT, I don't know how I practiced without the AdaptDx. Being able to diagnose AMD before we see any clinical signs and being able to monitor at the correct follow-up time for my patients that have AMD is wonderful. I felt like it was just a shot in the dark as to when I should have early AMD patients return, but now knowing their rod intercept, I can confidently say exactly when their follow-ups should be.
Prior to having the AdaptDx, I struggled with patients having complaints of night vision issues. Providing a recheck of their refractive findings and another look at their retina always came up negative. I knew this patient was providing me a legitimate complaint, but I could provide no clinical basis for this complaint. Now we test these patients using the AdaptDx and in minutes discover if their complaint is consistent with subclinical AMD. This allows me to not only diagnose their complaint, but the patient is also able to start treatment even earlier with supplementation and making lifestyle changes.
After five years of using the AdaptDx to help identify AMD at its earliest stage and then placing patients on a treatment regimen involving modifiable risk factors, I have documented many patients having improved Rod Intercept times (improved dark adaptation) and maintaining their visual acuity.
The first AMD symptom I noticed was problems reading in a dim room. When the light was bright, I had no issues. But when the light was dimmed, I just could not make out that small print.
Outside of the lane, there are four essential tests that I couldn’t practice without: OCT, fundus camera, visual field, and the AdaptDx.
We are the first eye care provider to offer the AdaptDx test in Canada! I realized I owed it to my patients to offer this innovative test to help with the early detection and management of AMD. Now, my practice gets to be the one that inspires others here in Canada to begin managing AMD earlier than ever before!
Having been a Vision Source Administrator for nearly 15 years, I know the mindset of the prototypical Vision Source doctor, and it is this: Seek out and deliver optimal patient care using the most up-to-date technology that is based on the latest peer-reviewed research. While accomplishing this worthy goal, the Vision Source doctor also watches to be certain that this increased level of care will simultaneously enhance the practice’s business well-being and also save money for the overall health care system with early diagnosis and treatment. Having also been trained extensively on dark adaptometry technology, I can wholeheartedly say that the AdaptDx instrument checks every single box for the Vision Source practitioner to accomplish all of these patient goals in the early detection and treatment of subclinical AMD.
I have made performing an AdaptDx test on all my patients that are over the age of 60 years old my standard of care. I have found that about 40% fail the rapid test, even when the macula looks perfect clinically. This has helped me to be able to begin proactive measures with patients that previously would have been overlooked until there was more advanced disease.
I feel that the AdaptDx instrument from MacuLogix is the most significant medical device breakthrough in my career! We finally have an instrument that measures the earliest detectable signs of AMD. We can now diagnose AMD before vision loss occurs!
The AdaptDx is the kind of optometric instrument that once implemented in your practice makes you think how you did so without it all this time. The ability to find AMD years before seeing changes in the retina by photography or OCT makes it a medical necessity for my practice and patients. Once I learned about it, I could no longer neglect that segment of my practice and had to have it! It is easy to use, can be profitable, and is the right thing to do for my patients. And our patients deserve the best!